Varyasin V.V. Varyasin

Varyasin V.V. Varyasin

Auto-generated profile, based on publicly available information

Varyasin V.V. Varyasin

City Clinical Hospital No. 52, 123182 Moscow, Russia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
LMLiudmila Mikhaleva
Liudmila Mikhaleva
ZGZarina Gioeva
Zarina Gioeva
VVValery Varyasin
Valery Varyasin
EBElvira Berezhnaja
Elvira Berezhnaja
RVRositsa Vandysheva
Rositsa Vandysheva
L(Lev Kakturskiy (Kakturskij)
Lev Kakturskiy (Kakturskij)
Amyloidosis is one of the rare systemic illnesses characterized by the deposition of amyloid fibrils in various organs and tissues. There is a common point between COVID-19 and systemic amyloidosis regarding the multiorgan involvement in the pathological process which leads to a heightened risk for severe morbidity and mortality in amyloidosis patients who contracted COVID-19. We performed a pathomorphological analysis of the autopsy records of 22 patients who had COVID-19 and pre-existing systemic amyloidosis. The premortem diagnosis of systemic amyloidosis was established in 55% of patients, and in other 45% of cases, amyloidosis was found at autopsy. Based on the results of immunohistochemical amyloid typing, amyloid A (AA) amyloidosis was detected in 23%, amyloid light chain (AL) lambda in 32%, AL kappa–in 9%, and transthyretin (ATTR) amyloidosis–in 36% of observations. Immunohistochemical staining with an antibody against SARS-CoV-2 Spike (S) protein revealed positive immune reactions in type II alveolocytes in 59% of deceased persons. The analysis of autopsy findings indicates that patients with systemic amyloidosis are more likely to experience an aggressive clinical course of COVID-19 which leads to a multiorgan failure and a higher risk of fatal outcome.

23 June 2023 in Nephrology
Verified
Journal Article
Closed access
FFFrolova N.F. Frolova
Frolova N.F. Frolova
VVVaryasin V.V. Varyasin
Varyasin V.V. Varyasin
VVVolgina G.V. Volgina
Volgina G.V. Volgina
SSSysoeva I.L. Sysoeva
Sysoeva I.L. Sysoeva
MMMudarisov R.R. Mudarisov
Mudarisov R.R. Mudarisov
ESEkaterina Stolyarevich
Ekaterina Stolyarevich

23 June 2023 in Nephrology
Verified
Journal Article
Closed access
TTTrushkin R.N. Trushkin
Trushkin R.N. Trushkin
TITeymur Isaev
Teymur Isaev
MMMedvedev P.E. Medvedev
Medvedev P.E. Medvedev
SSSokolov S.A. Sokolov
Sokolov S.A. Sokolov
PPParshin V.V. Parshin
Parshin V.V. Parshin
KKKlementieva T.M. Klementieva
Klementieva T.M. Klementieva